Table 2 Comparison of the results of angiographic data.
Study (year) | Late Lumen Loss [mean(SD)] | Minimum Lumen Diameter [mean(SD)] | Percentage Stenosis [mean(SD)] | |||
|---|---|---|---|---|---|---|
TZDs | Control | TZDs | Control | TZDs | Control | |
Takagai et al. (2003) | NR | NR | 2.00(0.50) | 1.50(0.60) | 32.0(16.0) | 47.0(16.0) |
Choi et al. (2004) | 0.65(0.73) | 1.20(0.97) | 2.49(0.88) | 1.91(1.05) | 23.0(23.4) | 40.6(31.9) |
Osman et al. (2004) | NR | NR | 1.50(1.10) | 1.40(0.90) | 55.4(26.1) | 57.7(28.3) |
Marx et al. (2005) | 0.88(0.41) | 1.08(0.85) | 2.14(0.46) | 1.94(0.91) | 22.1(12.7) | 33.3(23.3) |
Wang et al. (2005) | NR | NR | NR | NR | NR | NR |
Cao et al. (2006) | NR | NR | NR | NR | NR | NR |
Nishio et al. (2006) | 0.30(0.66) | 1.43(1.04) | NR | NR | NR | NR |
Katayama et al. (2007) | 0.56(0.38) | 0.97(0.46) | NR | NR | 21.5(9.44) | 38.6(17.4) |
Finn et al. (2009) | 0.62(0.59) | 0.70(0.67) | 1.61(0.57) | 1.60(0.78) | NR | NR |
Takagi et al. (2009) | 0.69(0.52) | 1.00(0.49) | 1.83(0.56) | 1.57(0.65) | 26.2(16.6) | 36.0(23.1) |
Kaneda et al. (2009) | 0.92(0.87) | 1.27(0.73) | 1.66(0.79) | 1.53(0.75) | 42.0(28.0) | 48.0(25.0) |
Hong et al. (2010) | 0.41(0.40) | 0.65(0.54) | 2.30(0.41) | 2.09(0.53) | 20.0(14.0) | 28.0(17.0) |
García-García et al. (2012) | 0.87(0.58) | 0.79(0.34) | 1.71(0.51) | 1.74(0.51) | 35.9(19.0) | 32.7(13.2) |
Lee et al. (2013) | 0.35(0.57) | 0.31(0.60) | 2.25(0.55) | 2.35(0.59) | 20.0(13.5) | 18.5(16.8) |
SMD (95% CI) | ||||||
For pioglitazone studies | −0.53(−0.84 to −0.22)* | 0.30(0.03 to 0.57)* | −0.48(−0.78 to −0.18)* | |||
For rosiglitazone studies | −0.17(−0.67 to 0.32) | 0.15(−0.19 to 0.49) | −0.16(−0.78 to 0.46) | |||
Overall | −0.42(−0.69 to −0.14)* | 0.24(0.04 to 0.44)* | −0.39(−0.67 to −0.12)* | |||
